J&J’s Rush To Market Made Mesh Patients Suffer, Jury Told
Law360, Philadelphia (April 16, 2019, 7:21 PM EDT) -- A Johnson & Johnson unit’s bid to protect its market dominance by rushing a pelvic mesh implant to market without sufficient clinical testing left a Philadelphia-area woman paying the price through worsening incontinence and pain she began experiencing with sex, a jury heard during closing arguments Tuesday.
Colin Burke, an attorney with Kline & Specter PC, told jurors that J&J subsidiary Ethicon Inc. had disregarded the health and safety of women like his client, Malgorzata Krolikowski, and launched its so-called TVT-Secur implant after testing it on only 31 people over a five-week period.
Of the 31 women who received the implant...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!